Although increasing evidence confirms neuropsychiatric manifestations associated mainly
with severe COVID-19 infection, long-term neuropsychiatric dysfunction (recently …

One increasingly documented tendency of COVID-19 patients is to exhibit neuropsychiatric
and neurological symptoms. Here we found that anxiety and cognitive impairment are …

… C Carregari; Laboratory of Neuroproteomics, Department of Biochemistry and Tissue
Biology, Institute of Biology, University of Campinas (UNICAMP), Campinas, Brazil; … C …

The development of new approaches allowing for the early assessment of COVID-19 cases
that are likely to become critical and the discovery of new therapeutic targets are urgently …

The COVID-19 pandemic was initiated by the rapid spread of a SARS-CoV-2 strain. Though
mainly classified as a respiratory disease, SARS-CoV-2 infects multiple tissues throughout …

As more uses for biomarkers are sought after for an increasing number of disease targets,
single-target biomarkers are slowly giving way for biomarker panels. These panels …

… Author links open overlay panel Licia C. Silva-Costa a , Bradley J. Smith a , Victor Corasolla
… -UDMS E method optimization we employed can be found in Silva-Costa et al. 2021 [31]. …

Major depressive disorder (MDD) is a complex and multifactorial psychiatric disorder that
causes serious health, social, and economic concerns worldwide. The main treatment of the …

Brain disorders are among the most complex and difficult to understand of human disorders
in terms of pathophysiology and etiology. Differently from other human diseases such as …

Major depressive disorder is a multifactorial disease, with molecular mechanisms not fully
understood. A breakthrough could be reached with a panel of diagnostic biomarkers, which …